Table 1 Demographic table.
From: Equivalence of the FCSRT and RAVLT to detect medial Temporal lobe atrophy and tauopathy
Average (standard deviation) [min, max] | Clinical syndrome classification | |||
|---|---|---|---|---|
Cognitively unimpaired | Cognitively impaired | Difference (p) | ||
N | 286 | 177 | 109 | NA |
Age | 70.5 (6.2) [51, 85] | 70.7 (5.8) [53, 85] | 70.2 (6.9) [51, 84] | 0.545 |
Education (years) | 15.3 (3.7) [6, 28] | 15.4 (3.6) [6, 26] | 15.3 (4.0) [6, 28] | 0.523 |
Sex (female) | 176 (61.5%) | 118 (66.7%) | 27 (56.3%) | 0.032 |
APOE ε4 carriers | 97 (33.9%) | 47 (26.6%) | 23 (47.9%) | < 0.001 |
FCSRT-IR | 28.4 (10.3) [1, 46] | 33.1 (5.3) [18, 46] | 20.4 (11.7) [1, 42] | < 0.001 |
FCSRT-DR | 10.3 (4.3) [0, 16] | 12.3 (2.0) [7, 16] | 6.9 (5.0) [0, 15] | < 0.001 |
RAVLT-IR | 8.8 (4.5) [0, 15] | 10.8 (3.0) [1, 15] | 5.5 (4.6) [0, 15] | < 0.001 |
RAVLT-DR | 8.4 (4.8) [0, 15] | 10.6 (3.1) [0, 15] | 4.7 (4.9) [0, 15] | < 0.001 |
N with A+ | 113 (39.5%) | 39 (20.3%) | 74 (67.9%) | < 0.001 |
N with plasma data | 139 | 93 | 49 | NA |
